Government Shutdown Poised to Become Longest in U.S. History

WSJ What’s News

The Wall Street Journal

News, Daily News

4 • 4K Ratings

🗓️ 4 November 2025

⏱️ 11 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

P.M. Edition for Nov. 4. WSJ’s Congress reporter Katy Stech Ferek talks about the latest in negotiations as lawmakers search for a deal to end the shutdown. Spencer Jakab, who writes WSJ’s Markets A.M. newsletter, explains why a famous method of valuing stocks suggests rough years ahead. And it’s Election Day in the U.S. Head to WSJ’s live blog for more coverage of key races in New York City, New Jersey and Virginia. Sabrina Siddiqui hosts. Sign up for the WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	This podcast is brought to you by Dinotrace, the leader in AI-powered observability,
0:04.3	with analytics, automation, and next-level intelligence on one unified platform.
0:08.3	Dinotrace delivers the visibility and real-time insights you need to deliver better,
0:12.2	more secure software, successful AI initiatives, and innovation at the speed of business.
0:16.8	Turn data into decisions that drive your business forward with AI-powered observability where it counts.
0:21.8	Learn more at dinotrace.com slash WSJ. That's www. dynatrace.com slash WSJ.
0:33.4	The government shutdown nears a record as the longest in U.S. history.
0:38.3	Plus, what an ominous milestone for a famous method of valuing stocks tells us about what's next for markets.
0:45.3	It's proven to be an extremely reliable indicator of what to expect in the several years ahead of us.
0:51.3	And former Vice President Dick Cheney, an architect of the U.S. War on Terror, has died at 84.
0:58.1	It's Tuesday, November 4th.
0:59.8	I'm Sabrina Siddiqui for the Wall Street Journal, sitting in for Alex Oslo.
1:03.4	This is the PM edition of What's News, the top headlines and business stories that move the world today.
1:16.5	Thank you. and business stories that move the world today. The Trump administration is negotiating with Eli Lilly and Novo Nordus to offer their
1:21.2	blockbuster weight loss drugs at lower prices, as low as $149 for a month's supply,
1:27.1	through a Trump-branded government website for buying medications.
1:30.9	People familiar with the matter say the proposed agreements would also mean Medicare and Medicaid coverage of expensive obesity drugs like Wagovi and Zepbound.
1:39.6	Medicare drug benefit plans today can cover the weight loss drugs drugs just not only for losing weight. For example,
1:46.4	they're available for reducing risk of heart attacks or sleep apnea. And few states offer Medicaid
1:51.6	coverage for the drugs for weight loss. And that's not the only news today about the weight loss
1:57.0	drug market. There's a new twist in the high-stakes bidding war for the obesity drug
2:01.6	developer Metzara, as Novo Nordisk and Pfizer have both raised their offers for the company.
	...

Transcript will be available on the free plan in 7 days. Upgrade to see the full transcript now.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from The Wall Street Journal, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Wall Street Journal and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.